MEF2B C-terminal mutations enhance transcriptional activity and stability to drive B cell lymphomagenesisChuanjiang Yu(Cancer Genetics (United States)), Katia Basso(Cancer Genetics (United States))Nature CommunicationsAugust 21, 202410.1038/s41467-024-51644-8Cited by 5SaveCiteExport RISWatch citationsRelated PapersSuper-enhancer hypermutation alters oncogene expression in B cell lymphoma|Nature|2022|154